Atea Pharmaceuticals
AVIR
#7429
Rank
NZ$0.49 B
Marketcap
$5.86
Share price
1.74%
Change (1 day)
18.96%
Change (1 year)

Earnings for Atea Pharmaceuticals (AVIR)

Earnings in 2024 (TTM): -NZ$0.29 Billion

According to Atea Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -NZ$0.23 Billion a decrease over its 2022 earnings that were of -NZ$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atea Pharmaceuticals from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.29 Billion27.43%
2023 -NZ$0.23 Billion12.92%
2022 -NZ$0.21 Billion-186.22%
2021 NZ$0.23 B-1366.01%
2020 -NZ$18.33 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.21 Billion-28.49%๐Ÿ‡บ๐Ÿ‡ธ USA